STOCK TITAN

Insider Dennis Mulroy plans ANAB (NASDAQ: ANAB) Rule 144 sale filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AnaptysBio (symbol ANAB) disclosed a planned insider sale of common stock under Rule 144. The notice covers 2,515 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 113,703.15. These shares come from restricted stock units acquired from the issuer on 01/08/2026, with cash as the form of payment.

The filing also lists recent sales by Dennis Mulroy over the prior three months. These include 1,908 shares sold on 01/07/2026 for 83,780.28, 3,363 shares on 01/05/2026 for 1,511,166.85, 10,000 shares on 12/22/2025 for 500,000, and 15,725 shares on 12/16/2025 for 705,333.1. The Rule 144 representation confirms the seller states they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ANAB Form 144 filing disclose?

The filing discloses a planned sale of 2,515 shares of ANAB common stock under Rule 144, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 113,703.15.

Who is selling ANAB shares in this Form 144 notice?

The Form 144 lists Dennis Mulroy as the person for whose account ANAB common shares are to be sold, and it provides his address and recent sale history.

What is the source of the 2,515 ANAB shares to be sold?

The 2,515 shares come from restricted stock units of ANAB common stock acquired from the issuer on 01/08/2026, with the consideration described as cash.

What recent ANAB stock sales by Dennis Mulroy are reported?

The filing reports sales of 1,908 shares on 01/07/2026 for 83,780.28, 3,363 shares on 01/05/2026 for 1,511,166.85, 10,000 shares on 12/22/2025 for 500,000, and 15,725 shares on 12/16/2025 for 705,333.1.

How many ANAB shares are outstanding as referenced in the filing?

The Form 144 indicates there are 27,688,470 ANAB common shares outstanding, which serves as a baseline figure relative to the 2,515 shares covered by this notice.

What representation does the seller make in the ANAB Form 144?

The seller represents that they do not know any material adverse information about ANAB’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.40B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO